latest news releases from the newsroom
Cell Power Technologies, Inc.
Cell Power Postpones Reverse Stock Split
BROOKLYN, N.Y., March 28, 2006 (PRIMEZONE) -- Cell Power Technologies, Inc. (OTCBB:CLPW) today announced that the 1-for-6 reverse split of its common stock that was scheduled to become effective as of the close of business on March 27, 2006, as announced in the company's press release dated March 21, 2006, has been postponed and will become effective as of the close of business on April 10, 2006.
Diamyd Medical AB
Diamyd Medical To Participate in Seattle-Sweden Childhood Diabetes Awareness Day Event
STOCKHOLD, Sweden, March 28, 2006 (PRIMEZONE) -- Diamyd Medical AB (Other OTC:DMYDF) (OMX:DIAMB), along with local institutions, will sponsor the first Seattle-Sweden Childhood Diabetes Awareness Day in Seattle, Washington on Saturday, April 1. The symposium, organized by Professor Ake Lernmark, Ph.D., working out of the University of Washington and Malmo, Sweden, and the Consulate General of Sweden in Los Angeles, will feature presentations by researchers from Seattle and Sweden, as well as biotech companies, including Diamyd Medical.
Delta Air Lines, Inc.
Delta's Atlanta Airport Experience to Undergo a Major Makeover
ATLANTA, March 28, 2006 (PRIMEZONE) -- Delta unveiled today that it will significantly improve its facility at Hartsfield-Jackson Atlanta International Airport, giving its customers more space, convenience and check-in choices. Plans include adding over 50 percent more lobby space, 24 more self-service kiosks with international check-in capability, redesigned gate seating, a new Crown Room Club and 14 new lower-level full service check-in positions.
Sports Concepts, Inc
Motion DNA to Beef Up Its Management Team and to Seek Fully Reporting Status With an Investment Banker
SCOTTSDALE, Ariz., March 28, 2006 (PRIMEZONE) -- Zig Ziegler, Founder, CEO and President of Motion DNA Corporation (Pink Sheets:MTDX), announced today that he intends to step down. "As I have always promised to do whatever possible to enhance shareholder value of our Company's stock, I have decided to relegate myself the role of Director of Marketing and Technical Development and allow for the infusion of a powerful slate of officers and directors to continue to guide our Company thru the everyday operations and dealing with non-core corporate activities," stated Ziegler.
Nannaco Announces Agreement to Acquire Internet Based Radiation Oncology Treatment Planning Firm
GIG HARBOR, Wash., March 28, 2006 (PRIMEZONE) -- Nannaco, Inc. ("Nannaco") (Pink Sheets:NANN) announced today that on March 17, 2006, it entered into an agreement and Plan of Merger with GAK Acquisition Inc., which owns the right to acquire Comprehensive Physics & Rehabilitation Services ("CPRS"), a Nevada corporation. On the effective date of the merger, Nannaco will issue an amount of shares representing 95% of the issued and outstanding shares of Nannaco to the shareholders of GAK Acquisition, Inc. and will be allowed to elect one person to the Board of Directors.
Gardant Pharmaceuticals, Inc.
Bioaccelerate Announces Sale of Subsidiary and First Distribution
NEW YORK, March 28, 2006 (PRIMEZONE) -- Bioaccelerate Holdings, Inc (OTCBB:BACL), which has previously announced that it is changing its name to Gardant Pharmaceuticals, Inc., today announced the sale of its wholly owned subsidiary, Cain Biotech, Limited, to Accura Pharma PLC, a United Kingdom-based company. Accura Pharma PLC is a privately held company that is in the process of listing for trading on a public exchange in the United Kingdom. In exchange for its interest in Cain Biotech, Limited, Bioaccelerate Holdings, Inc. received at closing 120 million shares of the common stock of Accura Pharma PLC. Those shares constitute approximately 60% of the outstanding common stock of Accura Pharma PLC.